5 Hyper-Growth Stocks Billionaires Are Loading Up On

2. Marinus Pharmaceuticals Inc (NASDAQ:MRNS)

Number of Billionaire Investors: 6

Marinus Pharmaceuticals Inc (NASDAQ:MRNS) is working on treatments of rare genetic epilepsies and other seizure disorders.

In November Marinus Pharmaceuticals Inc (NASDAQ:MRNS) posted third quarter results. GAAP EPS in the third quarter came in at -$0.61, beating estimates by $0.06. Revenue in the period jumped 213% year over year to $7.34 million, surpassing estimates by $1.03 million.

As of the end of the third quarter of 2023, six billionaires tracked by Insider Monkey had stakes in Marinus Pharmaceuticals Inc (NASDAQ:MRNS).